Login / Signup

A novel variant in DMXL2 gene is associated with autosomal dominant non-syndromic hearing impairment (DFNA71) in a Cameroonian family.

Edmond Wonkam-TingangIsabelle SchrauwenKevin Kum EsohThashi BharadwajLiz M Nouel SaiedAnushree AcharyaAbdul NasirSuzanne M LealAmbroise Wonkam
Published in: Experimental biology and medicine (Maywood, N.J.) (2021)
Approximately half of congenital hearing impairment cases are inherited, with non-syndromic hearing impairment (NSHI) being the most frequent clinical entity of genetic hearing impairment cases. A family from Cameroon with NSHI was investigated by performing exome sequencing using DNA samples obtained from three family members, followed by direct Sanger sequencing in additional family members and controls participants. We identified an autosomal dominantly inherited novel missense variant [NM_001174116.2:c.918G>T; p.(Q306H)] in DMXL2 gene (MIM:612186) that co-segregates with mild to profound non-syndromic sensorineural hearing impairment . The p.(Q306H) variant which substitutes a highly conserved glutamine residue is predicted deleterious by various bioinformatics tools and is absent from several genome databases. This variant was also neither found in 121 apparently healthy controls without a family history of hearing impairment , nor 112 sporadic NSHI cases from Cameroon. There is one previous report of a large Han Chinese NSHI family that segregates a missense variant in DMXL2. The present study provides additional evidence that DMXL2 is involved in hearing impairment etiology, and we suggest DMXL2 should be considered in diagnostic hearing impairment panels.
Keyphrases
  • hearing loss
  • intellectual disability
  • genome wide
  • copy number
  • single cell
  • gene expression
  • early onset
  • mass spectrometry
  • atomic force microscopy
  • circulating tumor cells